Navigation Links
Edwards Lifesciences Announces Retirement of Director Vernon Loucks
Date:4/16/2008

IRVINE, Calif., April 16 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in the products and technologies to treat advanced cardiovascular disease, announced today that Vernon R. Loucks Jr. is retiring from the company's board of directors, effective May 31, 2008.

Loucks, who is chairman of the Aethena Group, LLC, has been a director of Edwards since 2000, when the company was spun off from Baxter International Inc. as an independent, publicly-held corporation. Loucks previously served as Baxter's chairman and CEO.

"I want to express my sincere gratitude to Vern for his many contributions to Edwards both prior to and since our spin-off," said Michael A. Mussallem, Edwards' chairman and CEO. "He has been an exceptional advisor and significant partner to Edwards over the years. Vern's experience and perspective have been valuable to me professionally and personally, and I want to thank him for his commitment to Edwards."

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies. In 2008, Edwards celebrates 50 years of partnering with clinicians to develop life-saving innovations. The company's global brands, which are sold in approximately 100 countries, include CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Edwards Lifesciences to Host Earnings Conference Call on April 22, 2008
2. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
3. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
4. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
5. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
6. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
7. Edwards Lifesciences Reports Strong Fourth Quarter Sales
8. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
9. Edwards Lifesciences to Present at the Southern California Investor Conference
10. Edwards Lifesciences Announces Schedule of Activities at TCT 2007
11. Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: